<DOC>
	<DOCNO>NCT01153282</DOCNO>
	<brief_summary>Determine characteristic symptoms functional impairment associate chemotherapy induced peripheral neuropathy .</brief_summary>
	<brief_title>Physical Functional Side Effects Taxane Chemotherapy Breast Cancer</brief_title>
	<detailed_description>Taxanes , type chemotherapeutic agent prescribe breast cancer patient , know physical side effect chemotherapy induce peripheral neuropathy ( CIPN ) . The purpose qualitative study understand experience physical functional side effect taxanes . This first two phase study . The overall goal identify exist objective physical performance measure assess functional side effect taxanes .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Women 2170 year old ( Women 70 offer chemotherapy less frequently risk benefit ratio . Including would selection bias differential underexposure ) . Initiated taxanebased chemotherapy neoadjuvant , adjuvant , previously untreated metastatic setting . The range exposure taxanebased chemotherapy include woman active treatment receive two cycle , woman within three month last infusion . Documented symptom CIPN per CTCAE grade criterion ( half sample ) NO symptom ( half sample ) Grade 0 = CIPN symptom Grade 1 = mild symptom Grade 2 = moderate symptom prescribe Gabapentin ( Neurontin ) Grade 3 &amp; 4= severe symptom treat Gabapentin ( Neurontin ) , treatment plan alter Physical disability define use assistive device complete functional task ( wheelchair , crutch , prosthetic limb ) prior start chemotherapy . Current exposure neurotoxic agent ( Navelbine , platinums taxanes ) Pregnancy chemotherapy treatment Diabetes diagnose 3 year , insulin dependent , clinically establish neuropathy Previous exposure chemotherapy radiotherapy HIV positive ( high risk neuropathy ) Other neurological disease , Multiple Sclerosis Other preexist neuropathy</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Breast Cancer patient</keyword>
</DOC>